Christoph Bruening
Corporate Officer/Principal presso Value Relations GmbH
Posizioni attive di Christoph Bruening
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Value Relations GmbH | Corporate Officer/Principal | 01/01/1999 | - |
Storia della carriera di Christoph Bruening
Precedenti posizioni note di Christoph Bruening
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Callisto Pharmaceuticals, Inc.
 Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Direttore/Membro del Consiglio | 01/05/2003 | 26/05/2010 |
Statistiche
Distribuzione geografica
| Stati Uniti | 2 |
| Germania | 2 |
Posizioni
| Director/Board Member | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Health Technology |
| Value Relations GmbH |
- Borsa valori
- Insiders
- Christoph Bruening
- Esperienza
